| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V47594 | β-Lactamase-IN-8 | 1929555-36-1 | β-Lactamase-IN-8 (compound 20) is a potent, orally bioavailable, broad spectrum (a wide range) cyclic boronic acid β-lactamase (β-lactamase) inhibitor. |
|
V42977 | β-lactosyl-13C | β-lactosyl-13C is 13C (carbon 13)-labeled β-lactosy. | |
|
V43299 | β-Methylcrotonyl coenzyme A lithium | 108347-83-7 | β-Methylcrotonyl coenzyme A lithium is an intermediate in leucine metabolism and can be used as a substrate to study the specificity and kinetics of β-methylcrotonyl coenzyme A carboxylase (MCCase). |
|
V43226 | β-Nicotinamide adenine dinucleotide reduced dipotassium | 104809-32-7 | β-Nicotinamide adenine dinucleotide reduced dipotassium is an orally bioavailable reduced coenzyme. |
|
V47561 | β-Nor-lapachone | 52436-88-1 | β-Nor-lapachone is an anti-biofilm agent against Candida glabrata. |
|
V44666 | β-S-ARCA | 1093268-63-3 | β-S-ARCA is an analog of the 7-methylguanosine (m7G) cap structure of mRNA, carrying a phosphorothioate moiety. |
|
|
V50379 | γ-AA peptide P6 | γ-AA peptide P6, activator of E6 associated protein (E6AP) | |
|
V46585 | γ-L-Glutamyl-S-allyl-L-cysteine | 1299925-32-8 | γ-L-Glutamyl-S-allyl-L-cysteine is a naturally occurring organosulfur compound found in garlic. |
|
V46710 | γ-Secretase modulator 11 | 2434630-29-0 | 5-{8-[(3,4'-difluoro[1,1'-biphenyl]-4-yl)methoxy]-2-methylimidazo[1,2-a]pyridine-3- N-methylpyridine-2-carboxamide (1o) showed high in vitro potency and brain exposure, induced a significant reduction in brain Aβ42 levels, and exhibited undetectable inhibition of cytochrome p450 enzymes . |
|
V45827 | γ-Secretase modulator 11 HCl | 2434630-30-3 | γ-Secretase modulator 11 HCl (compound 1o) is a potent and orally bioactive γ-secretase modulator with IC50 of 0.029 µM. |
|
V46195 | γ-Secretase modulator 12 | 2204249-82-9 | γ-Secretase modulator 12 (Compound 1a) is a γ-secretase modulator that selectively reduces amyloid-β42 (Aβ42) levels (IC50 of 0.39 µM). |
|
|
V46541 | γ-Tocotrienol-d1 | 259522-16-2 | γ-Tocotrienol-d1, deuterium labeled Fmoc-Gly-OH |
|
V45745 | γ-Tocotrienol-d6 | 1174643-68-5 | γ-Tocotrienol-d6, deuterium labeled Fmoc-Met-OH |
|
V44311 | δ-Secretase inhibitor 11 | 842964-18-5 | δ-Secretase inhibitor 11 (compound 11) is an orally bioavailable, BBB (blood-brain barrier) permeable/penetrable, non-toxic, selective and specific δ-secretase inhibitor (antagonist) with IC50 of 0.7 μM. |
|
|
V48356 | Δ8,9-Dehydro-17β-estradiol-16,16,17-d3 | Δ8,9-Dehydro-17β-estradiol-16,16,17-d3, deuterium labeled Δ8,9-Dehydro-17β-estradiol-16,16,17 | |
|
V44811 | μ opioid receptor agonist 1 | 2667632-83-7 | μ opioid receptor agonist (activator) 1 (Compound H-1a) is an optically pure oxygen heterocyclic substituted pyrrolopyrazole analogue, used as a MOR receptor agonist (activator) and may be utilized in study/research of pain and pain-related diseases. |
|
V45102 | μ opioid receptor agonist 2 | 2671755-38-5 | μ opioid receptor agonist (activator) 2 (Compound H-3) is an optically pure oxygen heterocyclic substituted pyrrolopyrazole analogue, used as a MOR receptor agonist (activator) and may be utilized in study/research of pain and pain-related diseases. |
|
V44830 | σ1 Receptor/μ Opioid receptor modulator 1 | 2412700-00-4 | σ1 Receptor/μ Opioid receptor modulator 1 (Compound 44) is a potent σ1 receptor blocker (antagonist) and μ opioid receptor agonist (activator) with Ki of 1.86 nM and 2.1 nM, respectively. |
|
V41673 | ω-Muricholic acid | 6830-03-1 | ω-Muricholic acid (ω-MCA) is a mouse-specific secondary bile acid. |
|
V47635 | ∆14-Vincamenine | 112219-48-4 | Δ14-Vincamenine (14,15-Didehydrovincamenine) is a naturally occurring alkaloid compound. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
